|
| 37400643 | Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial. | Nat Med | 2024 |
| 37591790 | pH-Weighted amine chemical exchange saturation transfer echo planar imaging visualizes infiltrating glioblastoma cells. | Neuro Oncol | 2024 |
| 37581661 | Diffusion histogram profiles predict molecular features of grade 4 in histologically lower-grade adult diffuse gliomas following WHO classification 2021. | Eur Radiol | 2024 |
| 37882836 | Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRI. | Eur Radiol | 2024 |
| 37400643 | Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial. | Nat Med | 2024 |
| 37591790 | pH-Weighted amine chemical exchange saturation transfer echo planar imaging visualizes infiltrating glioblastoma cells. | Neuro Oncol | 2024 |
| 37581661 | Diffusion histogram profiles predict molecular features of grade 4 in histologically lower-grade adult diffuse gliomas following WHO classification 2021. | Eur Radiol | 2024 |
| 37882836 | Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRI. | Eur Radiol | 2024 |
| 36301349 | A multi-reader comparison of normal-appearing white matter normalization techniques for perfusion and diffusion MRI in brain tumors. | Neuroradiology | 2023 |
| 36301349 | A multi-reader comparison of normal-appearing white matter normalization techniques for perfusion and diffusion MRI in brain tumors. | Neuroradiology | 2023 |
| 35704275 | Amine-weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumors. | NMR Biomed | 2023 |
| 35639426 | Sex-specific brain microstructural reorganization in irritable bowel syndrome. | Pain | 2023 |
| 36435486 | Reproducible Microstructural Changes in the Brain Associated With the Presence and Severity of Urologic Chronic Pelvic Pain Syndrome (UCPPS): A 3-Year Longitudinal Diffusion Tensor Imaging Study From the MAPP Network. | J Pain | 2023 |
| 35853075 | Synthesizing MR Image Contrast Enhancement Using 3D High-Resolution ConvNets. | IEEE Trans Biomed Eng | 2023 |
| 38031316 | Spinal Cord Signal Intensity Predicts Functional Outcomes in the Operative Management of Degenerative Cervical Myelopathy. | Clin Spine Surg | 2023 |
| 37841696 | NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma. | Neurooncol Adv | 2023 |
| 37922934 | A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups. | Lancet Oncol | 2023 |
| 37584601 | Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways. | Cancer Discov | 2023 |
| 37790490 | Dendritic Cell Vaccination in Conjunction with a TLR Agonist Polarizes Interferon Immune Responses in Malignant Glioma Patients. | Res Sq | 2023 |
| 37554221 | Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma. | Neurooncol Adv | 2023 |
| 37864646 | Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma. | J Neurooncol | 2023 |
| 37152809 | A single-institution retrospective analysis of pathologically determined malignant transformation in IDH mutant glioma patients. | Neurooncol Adv | 2023 |
| 36831380 | Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign. | Cancers (Basel) | 2023 |
| 37402043 | The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I-III Studies. | Curr Oncol Rep | 2023 |
| 37027809 | Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma. | J Clin Oncol | 2023 |
| 36828377 | Structural Relationship between Cerebral Gray and White Matter Alterations in Degenerative Cervical Myelopathy. | Tomography | 2023 |
| 37019033 | Prospective, randomized, multicenter clinical trial evaluating longitudinal changes in brain function and microstructure in first-episode schizophrenia patients treated with long-acting injectable paliperidone palmitate versus oral antipsychotics. | Schizophr Res | 2023 |
| 36823302 | Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial. | Nat Med | 2023 |
| 36640127 | Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial. | Neuro Oncol | 2023 |
| 36702828 | Author Correction: Federated learning enables big data for rare cancer boundary detection. | Nat Commun | 2023 |
| 37128507 | Retrospective examination of pseudoprogression in IDH mutant gliomas. | Neurooncol Adv | 2023 |
| 37004331 | Effect of treatment with paliperidone palmitate versus oral antipsychotics on frontal lobe intracortical myelin volume in participants with recent-onset schizophrenia: Magnetic resonance imaging results from the DREaM study. | Schizophr Res | 2023 |
| 36617262 | Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival. | Neuro Oncol | 2023 |
| 36858729 | Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop. | Lancet Oncol | 2023 |
| 36539012 | A multi-omic brain gut microbiome signature differs between IBS subjects with different bowel habits. | Neuropharmacology | 2023 |
| 37294422 | Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas. | J Neurooncol | 2023 |
| 37167013 | Reply to Di Nunno et al. concerning objective response rates targets for recurrent glioblastoma clinical trials: Toward surrogate endpoints for phase II trials in patients with recurrent glioblastoma. | Neuro Oncol | 2023 |
| 36456893 | Qualitative and quantitative evaluation for the heterogeneity of cortical tubers using structural imaging and diffusion-weighted imaging to predict the epileptogenicity in tuberous sclerosis complex patients. | Neuroradiology | 2023 |
| 37540556 | Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma. | Clin Cancer Res | 2023 |
| 37542437 | Small pretreatment lesion size and high sphericity as favorable prognostic factors after laser interstitial thermal therapy in brain metastases. | J Neurosurg | 2023 |
| 37541280 | National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities. | Lancet Oncol | 2023 |
| 37864646 | Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma. | J Neurooncol | 2023 |
| 37554221 | Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma. | Neurooncol Adv | 2023 |
| 37584601 | Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways. | Cancer Discov | 2023 |
| 37790490 | Dendritic Cell Vaccination in Conjunction with a TLR Agonist Polarizes Interferon Immune Responses in Malignant Glioma Patients. | Res Sq | 2023 |
| 37841696 | NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma. | Neurooncol Adv | 2023 |
| 37542437 | Small pretreatment lesion size and high sphericity as favorable prognostic factors after laser interstitial thermal therapy in brain metastases. | J Neurosurg | 2023 |
| 37541280 | National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities. | Lancet Oncol | 2023 |
| 37540556 | Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma. | Clin Cancer Res | 2023 |
| 38031316 | Spinal Cord Signal Intensity Predicts Functional Outcomes in the Operative Management of Degenerative Cervical Myelopathy. | Clin Spine Surg | 2023 |